Flt3 Inhibitors In Aml Current Clinical Landscape And Key Insights From Trials

Summary

Join the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, as they dive deep into the complexities of In this episode of our podcast, we dive deep into the complexities of treating Blood Cancers Today spoke with Mehdi Hamadani, MD, chief of Hematologic Malignancies at the Robert Negrin, MD, Stanford University, Stanford, CA, discusses the evolving role of Richard M. Stone, MD, Dana-Farber Cancer Institute, Harvard In this discussion, Richard Stone, MD, Dana-Farber Cancer Institute, Boston, MA, Naval Daver, MD, The University of Texas MD ... In this video, Steven Knapper, DM, FRCPath, MRCP, BMBCh, Cardiff University, Cardiff, UK, shares Oncology Today with Dr Neil Love: Perspectives on New Datasets in Raoul Tibes, MD, PhD, physician-scientist at the University Hospital Head Myeloid Malignancies, Department of Internal Medicine ... In this video, Dennis Kim, MD, PhD, Princess Margaret Cancer Centre, Toronto, Canada, discusses the findings of a study ...